Download FREE Report Sample
Download Free samplePersonalized Medicine for Cancer Market contains market size and forecasts of Personalized Medicine for Cancer in Global, including the following market information:
Global Personalized Medicine for Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Personalized Medicine for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Personalized Medicine for Cancer include Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb and Ariad Pharmaceuticals (Takeda), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Medicine for Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicine for Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicine for Cancer Market Segment Percentages, by Type, 2021 (%)
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Global Personalized Medicine for Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicine for Cancer Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Global Personalized Medicine for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Personalized Medicine for Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Medicine for Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Personalized Medicine for Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
